Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $39.8300 (0.1%) ($38.8600 - $39.8300) on Mon. Mar. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.49% (three month average) | RSI | 41 | Latest Price | $39.8300(0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(59%) IBUY(58%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.745% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-12%) TBT(-7%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.745% (StdDev 5.49%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $29.75(-25.31%) | Resistance Level | $44.08 | 5 Day Moving Average | $41.72(-4.53%) | 10 Day Moving Average | $43.58(-8.6%) | 20 Day Moving Average | $44.08(-9.64%) | To recent high | -56.2% | To recent low | 0.1% | Market Cap | $2.474b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |